GlaxoSmithKline Pharmaceuticals
BSE: 500660 | NSE: GLAXO | ISIN: INE159A01016 | Pharmaceuticals
Yearly Results of GlaxoSmithKline Pharmaceuticals |
------------------- in Rs. Cr. ------------------- |
 |
|
|
Dec '04 |
Dec '05 |
Dec '06 |
Dec '07 |
Dec '08 |
|
| Sales Turnover |
1,375.89 |
1,470.38 |
1,538.42 |
1,570.30 |
1,685.56 |
| Other Income |
50.89 |
65.64 |
95.84 |
130.11 |
28.26 |
| Total Income |
1,426.78 |
1,536.02 |
1,634.26 |
1,700.41 |
1,713.82 |
| Total Expenses |
991.07 |
1,042.38 |
1,062.46 |
1,073.07 |
1,087.60 |
| Operating Profit |
384.82 |
428.00 |
475.96 |
497.23 |
597.96 |
| Profit On Sale Of Assets |
-- |
-- |
-- |
-- |
-- |
| Profit On Sale Of Investments |
-- |
-- |
-- |
-- |
-- |
| Gain/Loss On Foreign Exchange |
-- |
-- |
-- |
-- |
-- |
| VRS Adjustment |
-- |
-- |
-- |
-- |
-- |
| Other Extraordinary Income/Expenses |
-- |
-- |
-- |
-- |
-- |
| Total Extraordinary Income/Expenses |
67.04 |
195.80 |
183.79 |
137.94 |
128.21 |
| Tax On Extraordinary Items |
-- |
-- |
-- |
-- |
-- |
| Net Extra Ordinary Income/Expenses |
-- |
-- |
-- |
-- |
-- |
| Gross Profit |
435.71 |
493.64 |
571.80 |
627.34 |
626.22 |
| Interest |
-- |
-- |
-- |
-- |
-70.02 |
| PBDT |
502.75 |
689.44 |
755.59 |
765.28 |
824.45 |
| Depreciation |
17.47 |
15.73 |
15.85 |
16.16 |
16.34 |
| Depreciation On Revaluation Of Assets |
-- |
-- |
-- |
-- |
-- |
| PBT |
485.28 |
673.71 |
739.74 |
749.12 |
808.11 |
| Tax |
152.19 |
171.63 |
194.23 |
211.46 |
231.54 |
| Net Profit |
333.09 |
502.08 |
545.51 |
537.66 |
576.57 |
| Prior Years Income/Expenses |
-- |
-- |
-- |
-- |
-- |
| Depreciation for Previous Years Written Back/ Provided |
-- |
-- |
-- |
-- |
-- |
| Dividend |
-- |
-- |
-- |
-- |
-- |
| Dividend Tax |
-- |
-- |
-- |
-- |
-- |
| Dividend (%) |
-- |
-- |
-- |
-- |
-- |
| Earnings Per Share |
38.15 |
59.28 |
64.40 |
63.48 |
68.07 |
| Book Value |
-- |
-- |
-- |
-- |
-- |
| Equity |
87.32 |
84.70 |
84.70 |
84.70 |
84.70 |
| Reserves |
836.94 |
863.90 |
1,110.01 |
1,276.21 |
1,456.39 |
| Face Value |
10.00 |
10.00 |
10.00 |
10.00 |
10.00 |
|
|
|
|
| Source : Religare Technova |
| Explore GlaxoSmithKline connections |
|
